Symlinpen Injection
Product Images NDC 0310-6627

Product Visual Gallery

This gallery contains 47 technical images submitted to the FDA as part of the official labeling for Symlinpen (NDC 0310-6627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure C (120mcg plunger)

An illustration showing a syringe with a plunger inside. The image highlights the plunger component within the syringe barrel, suggesting a focus on the injection mechanism for administering a medication such as SymlinPen pramlintide acetate injection.*

FDA Label Image

Figure D (120mcg wipe off needle)

An instructional illustration showing hands peeling back the protective cap of a SymlinPen syringe, which contains pramlintide acetate injection. The image focuses on proper handling before subcutaneous use, depicting the pen and hands in black and white line art.*

FDA Label Image

Figure E (120mcg get new needle)

An instructional illustration depicting hands removing a protective cover from a pen needle, likely for the SymlinPen injection device containing pramlintide acetate. An arrow indicates the lifting motion to peel off the cover before use.*

FDA Label Image

Figure F (120mcg push capped needle on)

An instructional diagram showing the end of the SymlinPen injection device being fitted with an outer needle cover containing the needle. The illustration demonstrates how to attach the needle cover onto the pen for subcutaneous injection use.*

FDA Label Image

Figure G (120mcg pull off outer needle)

Illustration showing a hand holding a SymlinPen injection device covered with a needle cap. Arrows indicate actions: "Pull & Keep" for removing and retaining the needle cap, and "Throw Away" for disposing of a used component, demonstrating safe handling of the subcutaneous injection device.*

FDA Label Image

Figure H (120mcg turn dial to 60mcg)

Illustration showing the dose dialing mechanism of the SymlinPen injection device. It depicts how to adjust the dose by turning the dial near the pen's top, with a visible dose window indicating the selected dose in mcg. A finger is shown interacting with the dial to demonstrate use.*

FDA Label Image

Figure I (120mcg pull knob straight out)

An instructional illustration showing a close-up of a SymlinPen injection device with a focus on the dose knob. The image depicts a finger turning the knob, with an arrow indicating the direction for adjustment or preparation for injection. The illustration highlights the knob feature on the pen.*

FDA Label Image

Figure J (120mcg hold needle up)

An instructional illustration showing a hand holding a SymlinPen injector with a visible yellow label marked Symlin. The image demonstrates how to hold the pen and operate the push button on the bottom for subcutaneous injection of pramlintide acetate 1000 ug/mL.*

FDA Label Image

Figure K (120mcg turn dial to select dose)

An instructional diagram showing a close-up of a SymlinPen injection device. It depicts dialing a prescribed dose, with the dose displayed in a window (either 60 or 120) and an arrow indicating the rotation direction to set the dose. A hand is shown gripping the dial.*

FDA Label Image

Figure L (120mcg pull knob out)

An instructional illustration showing a finger pressing the knob on the SymlinPen injection device. The image highlights the knob mechanism for administering the pramlintide acetate 1000 mcg/mL injection by subcutaneous route.*

FDA Label Image

Figure M (120mcg turn knob)

An instructional illustration showing a SymlinPen dose indicator set to 60 mcg and a close-up highlighting that the pen does not have enough Symlin to deliver the full selected dose. The image advises users about insufficient medication volume for the dose.*

FDA Label Image

Figure N (120mcg check dose)

An instructional diagram showing dose alignment on the SymlinPen injection device dial. It highlights the correct positioning of the arrow, line, and dose number (60 mcg) on the dose selector to indicate that the full dose is loaded and ready for subcutaneous injection with SymlinPen pramlintide acetate 1000 ug/mL.*

FDA Label Image

Figure O (120mcg choose injection sight)

Illustration showing possible subcutaneous injection sites for SymlinPen (pramlintide acetate). Highlighted areas include the abdomen around the navel and the front part of the thighs, indicating where injections can be administered.*

FDA Label Image

Figure P (120mcg insert needle)

An instructional diagram showing a hand holding an injection syringe positioned for subcutaneous injection into the skin. The syringe is oriented horizontally, and the skin is labeled with an arrow, illustrating the injection process.*

FDA Label Image

Figure Q (120mcg push and hold for 10 seconds)

An instructional illustration showing a person administering a subcutaneous injection with the SymlinPen in the abdominal area. A circular icon indicates to press and hold the injection site for 10 seconds. The image demonstrates correct injection technique.*

FDA Label Image

Figure R (120mcg pull needle out)

An instructional illustration showing a hand wiping the chosen injection site on the abdomen with a wipe. Another hand holds the SymlinPen injection device, preparing for subcutaneous injection. The image depicts the step of cleaning the skin before administering the pramlintide acetate injection using the SymlinPen.*

FDA Label Image

Figure S (120mcg replace cover)

An instructional illustration showing a hand holding a SymlinPen injection device with the outer needle cover about to be removed, indicated by an arrow. The image visually guides users on the step to remove the needle cover before subcutaneous injection.*

FDA Label Image

Figure T (120mcg unscrew cap)

Illustration showing a close-up of a hand holding a SymlinPen injection pen, demonstrating the method to twist and remove the pen cap by rotating it counterclockwise and pulling it off. This instructional image is related to the SymlinPen 1000 ug/mL subcutaneous injection by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Figure U (120mcg replace cap)

An instructional illustration showing a hand holding the SymlinPen injection device, with a pen cap indicated by an arrow. The diagram highlights that the pen cap covers the pen when not in use, demonstrating proper handling of the subcutaneous injection pen for pramlintide acetate.*

FDA Label Image

Pramlintide Acetate Chemical Structure (Image 01)

Chemical structure description of pramlintide acetate showing the amino acid sequence with a disulfide bridge between two cysteine residues. This represents the active ingredient in SymlinPen injection 1000 mcg/mL by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Figure 1 (Image 02)

A line graph displaying plasma concentrations of Amylin and Insulin over time in a 24-hour period. The x-axis represents time from 7 am to midnight, marked with meal times. The left y-axis shows plasma Amylin levels in pM, and the right y-axis shows plasma Insulin levels in pM. Two data series are plotted: Amylin with triangles and Insulin with circles, depicting concentration fluctuations in relation to meal intake.*

FDA Label Image

Figure 2 (Image 03)

Three line graphs showing mean plasma glucose concentration (mg/dL) over time relative to a meal (minutes) for insulin treatment in type 1 and type 2 diabetes patients. The top graph compares lispro insulin with a combination of 120 mcg SYMLIN plus lispro insulin in type 2 patients. The lower graphs show regular insulin alone versus the same combination in type 1 patients. Data points are shown with distinct markers for each treatment.*

FDA Label Image

Figure A (Pen Parts)

An instructional diagram detailing the parts of the SymlinPen 120 pre-filled pen injector containing pramlintide acetate injection 1000 ug/mL. The labeled pen components include the pen cap, pen label with expiration date, clear colorless liquid cartridge, dosage dial, dose window, knob for loading and injecting, and dose check indicator showing lines, arrows, and numbers.*

FDA Label Image

Figure B (Attach Pen Needle (needles not included))

An instructional diagram titled 'Attach Pen Needle (needles not included)' showing step-by-step how to attach a needle to an injection pen. It includes removing a paper tab, pushing and screwing the needle onto the pen, removing and saving the outer needle cover, and removing and discarding the inner needle cover. The diagram labels the inner needle cover, outer needle cover, needle, and paper tab.*

FDA Label Image

Figure A (Pen Parts)

An instructional diagram showing the parts of the SymlinPen 60 injection device. It identifies the pen cap, pen label with expiration date, cartridge containing clear colorless liquid, dial for adjusting dose, window showing dialed dose, knob to pull and spin for dose adjustment and push to inject, and dose check indicators with lines, arrows, and numbers.*

FDA Label Image

Figure B (Attach Pen Needle (needles not included))

An instructional diagram titled 'Attach Pen Needle (needles not included).' It shows step-by-step directions with labeled visuals on removing the paper tab from the outer needle cover, pushing the needle straight onto the pen, screwing it on tight, then removing and saving the outer needle cover while discarding the inner needle cover before use.*

FDA Label Image

Figure C (60mcg plunger)

An instructional illustration showing a cross-section of a SymlinPen injection device. It highlights the plunger inside the syringe barrel, demonstrating the mechanism used for subcutaneous delivery of pramlintide acetate at a concentration of 1000 mcg/mL.*

FDA Label Image

Figure D (60mcg pull cap off)

An instructional illustration showing hands holding a SymlinPen subcutaneous injection device. One hand is gripping the pen while the other is peeling away a protective cap or cover from the pen's tip, demonstrating preparation for injection.*

FDA Label Image

1.5 mL Pen-injector Carton (Image 10)

Packaging label for SymlinPen 60 pen-injector containing pramlintide acetate at 1000 mcg/mL concentration. The label indicates two disposable 1.5 mL multidose pen-injectors for subcutaneous use with doses of 15, 30, 45, and 60 mcg. It is labeled for single patient use only and manufactured by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

2.7 mL Pen-injector Carton (Image 11)

SymlinPen 120 (pramlintide acetate) pen-injector label shows two 2.7 mL disposable multidose pen-injectors containing 1000 mcg/mL pramlintide acetate, with dosage strengths of 60 and 120 mcg. The label is marked for single patient use only, subcutaneous injection, and specifies that pen needles are not included. Manufactured by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Figure E (60mcg pull top off)

An instructional illustration showing a hand peeling off a protective seal from a pen needle cap, with an arrow indicating upward removal. This image likely relates to preparation or assembly of the SymlinPen injection device.*

FDA Label Image

Figure F (60mcg push capped needle on)

An instructional illustration showing a hand removing the outer needle cover containing the needle from the SymlinPen injection device. The diagram labels the end of the pen and the outer needle cover, demonstrating the step to remove the needle cover before use.*

FDA Label Image

Figure G (60 mcg push capped needle off)

An instructional illustration showing a hand holding a needle cap for the SymlinPen injection device. It demonstrates pulling the cap off and keeping it, while the needle is to be thrown away. The image guides safe needle removal and disposal.*

FDA Label Image

Figure H (60mcg select dose)

An instructional illustration showing the dial and window of a SymlinPen injection device. It depicts a finger adjusting the dial to set a dose, with the number 15 visible in the window, indicating dose selection for subcutaneous injection of pramlintide acetate.*

FDA Label Image

Figure I (60mcg pull knob out)

An instructional diagram showing a person pressing the knob on the SymlinPen injection device, indicating the knob's function for administering a subcutaneous injection of pramlintide acetate. The diagram highlights the knob with an arrow pointing to it and a red arrow showing the direction of pressing.*

FDA Label Image

Figure J (60mcg hold needle pointing up)

An instructional illustration showing a hand holding the SymlinPen injection device with the thumb pressing the bottom button labeled 'Push' to administer the dose. The pen is labeled with SymlinPen and contains dose indicators for subcutaneous injection.*

FDA Label Image

Figure K (60mcg turn dial to select dose)

An instructional illustration showing the dial of a SymlinPen injection device. The dial is set to 15 units, with a hand adjusting the dial. A label next to the dial indicates you can choose a prescribed dose of 15, 30, 45, or 60 units. The pen's window displays the selected dose number.*

FDA Label Image

Figure L (60mcg pull knob out)

An instructional illustration showing a hand adjusting the dosage knob of a SymlinPen injection device, used to administer pramlintide acetate subcutaneously. The diagram highlights how to turn the knob to select the dose before injection.*

FDA Label Image

Figure M (60mcg turn knob forward)

An instructional illustration showing a close-up view of the SymlinPen dose display indicating an incorrect dose setting with a partial dose indicator less than 15 units. It advises that the pen does not have enough Symlin for the full dose.*

FDA Label Image

Figure N (60mcg check line)

An instructional diagram showing a close-up of the SymlinPen dose display with an arrow pointing to the number 15, accompanied by labels identifying the arrow, line, and number of dose, indicating that a full dose is loaded in the pen.*

FDA Label Image

Figure O (choose injection site)

An illustration showing possible injection sites for Symlin (pramlintide acetate) on a human body. Highlighted areas include the abdomen around the navel and the front of both thighs, indicating recommended subcutaneous injection locations for Symlin.*

FDA Label Image

Figure P (60mcg insert needle into skin)

An instructional illustration showing the correct way to hold and inject SymlinPen, an injection pen for pramlintide acetate 1000 ug/mL, subcutaneously under the skin. The image highlights the pen placement in relation to the skin and demonstrates the hand grip on the injection device.*

FDA Label Image

Figure Q (60mcg hold for 10 seconds)

An instructional illustration showing the subcutaneous injection of SymlinPen (pramlintide acetate) into the abdomen. The image indicates to press and hold the pen in place for 10 seconds after injection.*

FDA Label Image

Figure R (60mcg push knob until click)

An instructional illustration showing a hand wiping a chosen injection site on the abdomen while holding the SymlinPen Injection (pramlintide acetate) in the other hand, demonstrating preparation for subcutaneous administration.*

FDA Label Image

Figure S (60mcg replace cover)

An instructional diagram showing a hand holding a SymlinPen injection device, with an arrow indicating the removal of the outer needle cover from the pen. The illustration highlights the outer needle cover as a detachable component of the subcutaneous injection device.*

FDA Label Image

Figure T (60mcg unscrew capped needle)

Illustration showing a hand holding the cap of an injection pen with a red arrow indicating the removal direction by twisting or pulling the cap off from the pen device, likely demonstrating how to prepare the SymlinPen for use.*

FDA Label Image

Figure U (60mcg replace cap)

An instructional illustration showing how to remove the pen cap from the SymlinPen injection device. The diagram depicts a hand gripping the pen and another hand pulling off the pen cap to reveal the threaded pen tip, with an arrow indicating the direction to remove the cap.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.